Skip to content

KNSA

Kiniksa Pharmaceuticals, Ltd.

NASDAQ · BMHealthcareBiotechnology
$62.58-2.14%

Price as of Jul 20, 2026

KNSA capital

Kiniksa Pharmaceuticals, Ltd. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-0.30x
Debt / assets
0.01x
Debt / EBITDA
0.08x
Net debt / EBITDA
-1.68x

Liquidity & coverage

Current ratio
3.79x
Quick ratio
3.33x
Cash ratio
2.99x
Interest coverage
EBITDA / interest
Working capital
$437.6M

Cash & dividend

FCF / debt
18.20x
Cash flow / debt
18.38x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.